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PrescriberAbstract Introduction: In the context of the continuous quest to improve the care of the neonates
especially the critically ill premature, the extended role of pharmacists in the process of parenteral
nutrition order writing and effective participation in decision-making especially in the neonatal
population is increasingly important.
This review aims to present results from literature review of available evidence on the pharma-
cists’ role in neonatal parenteral nutrition therapy.
Material and methods: Key medical, clinical, and review databases were searched; relevant arti-
cles were retrieved and evaluated.
Results and discussion: A total of 19 papers out of 7127 searched papers met the criteria for
inclusion, discussing the review topic.
The main focus of the selected papers was on parenteral nutrition practice as related to the
pharmacy practice.
The overall quality of studies was mixed.
Conclusion: Overall, the review presents the up-to-date status of the most recent analysis being
undertaken on the topic of pharmacist involvement in the parenteral nutrition order writing
practices and more speciﬁc in the neonatal population over the period from 1979 to 2013.
430 M.H. Ragab et al.The overall impression is that the practice of pharmacist writing neonatal parenteral nutrition
orders already exists, but still limited if compared with the practice pharmacist writing adult paren-
teral nutrition orders which is much more established in many countries.
There was no single clinical study evaluating this practice, as we were able to retrieve only two
surveys, which make it difﬁcult to evaluate the pharmacists’ role in this area.
Nevertheless, despite the wide variation in literature types, characteristics and quality, there are
consistent patterns across all the reviewed literature that competencies of the pharmacist in this ﬁeld
are well represented, which make it very important to carry out good quality clinical studies in this
ﬁeld.
Finally, we are currently conducting a prospective clinical study to evaluate the impact of clinical
pharmacist as a neonatal PN prescriber, this impact will be judged through the study outcomes as
reducing the metabolic and electrolytes complications and increasing the mean daily weight gain
during PN therapy and reducing the average number of days of PN till enteral feeding is achieved.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Contents
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Neonates are the most patients population that beneﬁts from
parenteral nutrition therapy, asmost of the prematures and very
lowbirthweight infants<1500 gwill need immediate after birth
nutrition support therapy through parenteral access due to their
inability to tolerate/contraindicated enteral or oral feeding. As
such, parenteral nutrition (PN) is an essential component of care
for those infants. There is good evidence that some preterm
infants may fail to grow adequately (Ehrenkranz et al., 1999;
Wood et al., 2003). Poor growth can be associated with poor
neurodevelopmental outcomes in extremely preterm infants,
with a lower weight at discharge associated with an increased
risk of neurodevelopmental impairment (Ehrenkranz et al.,
2006). One reason for this poor growthmay be that these infants
receive inadequate nutrition in the ﬁrst weeks of life.
Recommendations for the optimal nutrient intake of preterm
infants exist (Agostoni et al., 2010), however, there is evidence
that these targets are not achieved (Embleton et al., 2001;
Grover et al., 2008; Martin et al., 2009). Achieving recom-
mended nutrient intakes in these infants is a major challenge,
and feeding practices can be variable. This was demonstrated
by Cooke et al. (2004) who showed that units offering the same
level of care had signiﬁcant variations in postnatal growth.
Another unique problem, frequently encountered with the neo-
natal parenteral nutrition ordering practice is the provision of
low calories and failure to reach the minimum required calories
needed for proper weight gain, and this problem is of greatsigniﬁcance as the single most important goal for neonatal
parenteral nutrition is to maximize weight gain and provide
enough calories and protein to build new tissues. And to ensure
the provision of the required calories and protein for those
infants; the pharmacist input is of great signiﬁcance as to calcu-
late the daily provided calories and protein – from parenteral
and enteral nutrition – for the infants and to modify the paren-
teral nutrition orders accordingly until reaching the goals.
Understanding the barriers to implementing a change in
practice is key to the development of a successful intervention
(Grol, 1997; Grol and Grimshaw, 2003), and there is evidence
that guidelines alone are often not enough to bring about or
maintain a change in practice, and thatmoremultifaceted imple-
mentation strategies are required (Grimshaw et al., 2004; Grol,
2001; Grol and Grimshaw, 2003; Mettes et al., 2010).
Evidence demonstrates that physicians have minimal train-
ing and experience in this area of nutrition support (Gales and
Riley, 1994), and consequently this has led to the development
of multidisciplinary nutrition support teams in many health
care facilities (Naylor et al., 2004). According to a position
paper by the European Society of Paediatric Gastroenterology,
Hepatology and Nutrition (ESPHGAN) Committee on Nutri-
tion, current education of pediatricians in clinical nutrition is
insufﬁcient to ensure appropriate assessment of nutritional risk
(Agostoni et al., 2005).
Improvements can be made in the nutrition support pro-
cess. The nutrition support pharmacist will be a key partici-
pant in the maintenance and improvement of the nutrition
Neonatal parenteral nutrition 431care process (Mirtallo, 2007). In a recent article, reviewers
proposed a paradigm shift of pharmacy nutrition support to
move beyond PN and drug-nutrient interactions and become
partners in the interdisciplinary approach to nutrition care
plans and offer their assistance with the nutrition care plan’s
implementation and monitoring of its effectiveness (Mirtallo
and Sacks, 2013).
In the context of our continuous quest to improve the level
of care to the neonates especially the critically ill prematures,
the extended role of pharmacists in the process of parenteral
nutrition order writing and effective participation in decision
making especially in the neonatal population is increasingly
important to better utilizing the pharmacists’ vast pharmaceu-
tical, pharmacological and clinical knowledge.
In this review we are mainly concentrating on the current
areas of involvement for pharmacist in the neonatal parenteral
nutrition practice. Also we aim at determining the impact of
the pharmacist involvement in this practice on the patients’
clinical outcomes and/or cost optimization of PN therapy.
Throughout this review we will investigate if the pharmacist
as a prescriber of neonatal PN orders had favorable impact
on the patients’ clinical status.2. Materials and methods
An extensive literature review was conducted across various lit-
erature databases including, British Medical Journals (BMJ),
Cochrane Library Database, EBSCO, Karger Journals, OVID
SP, SAGE Journals, Science Direct, Scopus Database, Springer
Link, Web Of Knowledge (ISI).
The search was conducted based on a diversity of key
words related to the review topic, during the period from
1979 to 2013.
Keywords used for searching in various data sources:
Neonate, Neonatal intensive care unit, premature, preterm,
parenteral nutrition, total parenteral nutrition, pharmacy, clin-
ical pharmacist, and pharmacist.
The articles were included in the ﬁnal review only if they
focused on and/or reported the pharmacists’ involvement in
parenteral nutrition practice other than the compounding of
parenteral nutrition admixtures.
Then the results were reviewed to exclude the irrelevant
articles, the articles were excluded from the ﬁnal review if they
were not reporting any involvement of the pharmacist in par-
enteral nutrition practice except only the compounding and
preparation of parenteral nutrition admixtures.
Finally there were 19 articles matching the review topic.
The selected articles were classiﬁed according to their type as:
Commentary review (no. = 1), Descriptive review (no. = 4),
Survey (no. = 6), Systematic review (no. = 1), Retrospective
studies (no. = 2), Prospective study (no. = 3), Standards of
practice (no. = 1), other (no. = 1).3. Results
The key characteristics of the 19 literatures selected for inclu-
sion in the ﬁnal review out of 7127 searched published papers
are outlined in Table 1.
The search conducted over the previously mentioned dat-
abases yielded the following results:British Medical Journals (BMJ) 310 Papers, Cochrane
Library Database 126 Papers, EBSCO 150 Papers, Karger
Journals 49 Papers, OVID SP 5252 Papers, SAGE Journals 57
Papers, ScienceDirect 112 Papers, ScopusDatabase 145 Papers,
Springer link 113 Papers, and Web Of Knowledge 813 Papers.
The included literatures cover a wide range of different
pharmacists’ involvement in neonatal parenteral nutrition
practice, ranging from only compounding the PN admixtures
through monitoring and participation in the decision-making
process to the point of writing PN orders.
Worth mentioning that the deﬁnitions of pharmacist
involvement in the PN therapy varies across the literature
and in a number of cases, adequate descriptions of the involve-
ment being studied were relatively limited, making compari-
sons more difﬁcult.
Also it was noticed that there was a wide range of variation
related to the quality of literature ranging from prospective
studies all the way to just commentary article.
Finally few articles were discussing the pharmacist involve-
ment in neonatal PN ordering process, while most of the articles
were focusing on other outcomes and occasionally reporting the
pharmacist involvement in PN practice, this ﬁnding make it
much more difﬁcult to extract these data related to the scope
of our review.
4. Discussion
Based on the results of the literature search outlined in Table 1,
the focus of the literature was beneﬁts of nutrition support
team: (n = 2), variable levels of pharmacist involvement in
PN, other than writing PN orders: (n = 9), beneﬁts of pharma-
cist involvement in PN: (n = 5), pharmacist writing PN orders:
(n = 6), and pharmacist writing neonatal PN orders: (n = 2).
From this stratiﬁcation we noticed that only 2 articles
(Ahmed et al., 2004; Mulholland, 2013) were focusing on phar-
macist writing neonatal PN orders, and these articles were
both surveys, which raise the need for more in-depth research
to evaluate the beneﬁts of pharmacist writing neonatal PN
orders from the clinical point of view, also we need more clin-
ical trials in this area.
4.1. Beneﬁts of nutrition support team
This was discussed in two articles, the ﬁrst conﬁrm that the
cost of PN will be reduced with the NST (Naylor et al., 2004).
The second article conﬁrms fewer metabolic abnormalities
with the NST (Gales and Riley, 1994).
Both articles were focusing on adult cases only.
4.2. Variable levels of pharmacist involvement in PN, other than
writing PN orders
Most of the literature lies in this category as there are 9 articles
focusing on different levels of pharmacist involvement in PN.
1. Nutrition care plan’s implementation and monitoring
(Mirtallo and Sacks, 2013).
2. Nutrition consultations (MacLaren et al., 2006;
Pedersen et al., 2011).
3. Compounding of PN and are responsible for the logis-
tical aspects and integrity of the PN product lines
(Batani et al., 2007).
Table 1 Characteristics of included literatures.
Sr. No. Author, year Country Design Number of studies/
respondents/patients
Patients Population
studied
Limitations Main outcomes
1 Mirtallo and
Sacks (2013)
USA Commentary review – –  Literature design is weak.
 Subjective opinion.
 Not focusing on neonatal
population.
They proposed a paradigm shift of
pharmacy nutrition support to move
beyond PN and drug-nutrient
interactions and become partners in
the interdisciplinary approach to
nutrition care plans and oﬀer their
assistance with the nutrition care
plan’s implementation and
monitoring of its eﬀectiveness.
2 MacLaren et al.
(2006)
USA Questionnaire
survey (Sent by
mailings to
pharmacy directors
of all US institutions
with an ICU).
Of 3238 institutions 382
institutions responded
corresponding to 1034
ICU’s. (Respondents are
pharmacy directors)
Adult ICU patients  Not focusing on neonatal
population.
 Not clear the level of pharmacists’
involvement in parenteral nutri-
tion practice.
Pharmacists provide formal nutrition
consultations to ICU’s.
3 Naylor et al.
(2004)
Australia Systematic review 11 clinical studies (4 with
concurrent controls and 7
with historical controls)
All adult cases
The age of patients in the
studies ranged between
26 and 93 years
 Focusing on the impact of nutri-
tion support team but nothing
speciﬁc to pharmacist.
 Only adult patients.
The data, although limited, support a
reduction in costs for patients
managed by the TPN team.
4 Ahmed et al.
(2004)
UK Telephone survey of
middle grade
doctors (Specialist
Registrars) working
in all neonatal units
in England,
Scotland, and Wales
with 6 or more
intensive care cots
(total of 57 units).
54 neonatal units out of 57
units responded (95%)
NICU neonates  Only physicians were surveyed.
 Not focusing on the pharmacist
involvement.
 Subjective opinions.
 Only the number of units is
reported but the actual number
of physicians surveyed is not
mentioned.
 Only one third of the units involve
a pharmacist in the PN
prescribing.
 In only 3 units the person respon-
sible for ordering PN was a
pharmacist.
 There is a diverse practice and
knowledge with a concerning lack
of education in nutrition among
the middle grade doctors in Eng-
land, Scotland, and Wales.
 The management of common
complications such as sepsis and
hyperglycemia are highly variable.
 We suggest that the involvement
of nutrition teams in all neonatal
units would help reduce PN
complications.
 There is a need for further train-
ing of junior doctors in prescrib-
ing of PN along with the
involvement of pharmacists to
ensure safety.
4
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5 Batani et al.
(2007)
Malaysia Retrospective study 215 TPN cases Mixed:
 Neonates 22.8%,
 Pediatrics 11.2%,
 Adults 64.6%.
 Not focusing on pharmacists’
involvement in PN practice.
 Pharmacists were only com-
pounding the PN.
 The neonatal population was only
22.8% of cases.
 NST pharmacists have been
acknowledged as experts in the
compounding of PN and are
responsible for the logistical
aspects and integrity of the PN
product lines.
 The ﬁnding of this study is proof
that the TPN service is associated
with a high rate of complications;
however, TPN has favorable
outcomes.
 Electrolyte complications are the
main complications encountered
by the TPN patients and the rate
was 56.5%, which is higher com-
pared with that in advanced
countries.
6 Yang et al.
(2013)
Korea Retrospective study 56 neonates in standard
protein group, and 53
neonates in high protein
group
Very low birth weight
neonates (with birth
weights <1500 g and
gestational ages between
24 ± 0 weeks and
33 ± 6 weeks)
 Not focusing on the pharmacist
involvement in PN.
 Study focus on the effect of high
versus standard protein
supplementation
In this program, the daily amount
and calories provided by each major
nutrient were automatically
calculated from the individualized
PN and enteral feeding orders, which
were conﬁrmed or modiﬁed by a
neonatal pharmacist
7 McDermott
et al. (1994)
USA Descriptive review – Adults  No statistical analysis provided.
 Subjective opinion.
 Mixed population and no clear
mentioning of neonatal PN.
The results of the increased inﬂuence
of pharmacists on the prescribing
process included:
 More appropriate parenteral
nutrition therapy,
 Earlier transitioning from paren-
teral to enteral nutrition,
 Recognition of staff pharmacists
as resources by the physicians,
 And increased job satisfaction for
pharmacists.
8 Seres et al.
(2006)
USA Web based survey,
(Results of the 2003
American Society for
Parenteral and Enteral
Nutrition Survey)
651 respondents:
 Pharmacists 32%,
 Dietitians 55%,
 Nurses 5%,
 Physicians 7%,
 Others 1%.
Mixed patients. (No
speciﬁc mention of the
patients’ age groups)
 Not focusing on neonatal
population.
 Subjective opinions.
 No statistical analysis provided.
 Respondents indicated that dieti-
tians and pharmacists were heav-
ily involved in the order-writing
process, either as individuals or
as members of a nutrition support
service.
 The pharmacy was allowed to
adjust certain electrolyte additives
such as acetate or chloride in 62%
of respondent’s organizations.
 The oversight of the order-writing
process was most often the
responsibility of the pharmacy
(71%).
(continued on next page)
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Table 1 (continued)
9 Greenlaw (1979) USA Descriptive review – Adults  No clear mention of neonatal PN.
 Subjective opinion.
 No statistical analysis provided.
 The number of patients
receiving TPN therapy
has increased each year,
from six patients during
1976, to 19 patients during
1977 and 54 in 1978.
 Of the two preventable
complications that
developed in these 79
patients, both were
quickly resolved by the
pharmacist.
 Physicians, who, in the past,
opted not to place patients
on TPN because of lack
knowledge or lack of a TPN
consultant, now rely on the
pharmacist for this service.
10 Mutchie et al. (1979) USA Prospective study Group 1 & group 2,
26 patients in each
group, of which, 6 in
each neonatal
subgroup.
Mixed population;
In each group 20
non-neonatal
patients, In each
group 6 neonatal
patients
 Small neonatal subgroups sample size
(6 patients in each group).
 Not clear the monitoring activities
done by pharmacists.
 No clear mentioning the order writing
practices for pharmacists.
 Pharmacist monitoring of
TPN reduced the pharmacy’s
costs and patient charges for
TPN and improved the
patients’ clinical responses
to TPN.
11 Mulholland (2013) UK Questionnaire Survey, for
Pharmacists working in neonatal
intensive care units
45 respondents Neonates in
neonatal intensive
care units
 Subjective opinions
 No statistical analysis.
 Small sample size.
The main medicines being
prescribed were Parenteral
Nutrition (PN) (75%).
Beneﬁts of pharmacist prescribing:
 Improvement in safety was
seen as a beneﬁt of pharmacist
prescribing, with potential
reduction in communication
errors (with the pharmacist
making a change in medication
or dosage, rather than asking
a doctor to do it) and the
ability to make timely
correction of wrong
prescriptions.
 Pharmacist knowledge
of PN and pharmacokinetics
were seen to be better utilized
with the person advising now
also taking the prescribing
responsibility.
 It was also felt that being a
prescriber helped the
pharmacist to integrate more
into the multidisciplinary team.
4
3
4
M
.H
.
R
a
g
a
b
et
a
l.
12 Ro llins et al.
(2008)
USA ASPEN standards of
practice for nutrition
support pharmacists
– Adults, pediatrics, and
neonates
 Not focusing on neonatal PN.
 Not mentioning the beneﬁt
of pharmacist writing PN
orders.
Standards of Practice for Nutrition
Support Pharmacists:
Standard 2.6:
 The nutrition support pharmacist
may write orders for feeding for-
mulations and laboratory tests,
and adjust regimens based on
response to therapy, changing
clinical conditions, and nutrition
parameters as delineated by clini-
cal privileges and applicable pro-
fessional licensure laws.
13 Boullata et al.
(2013)
USA Web-based survey 895 respondents:
 Pharmacists 54%,
 Dietitians 38%,
 Nurses 3.5%,
 Physicians 3.2%.
Mixed population and
not clearly mentioning
the neonatal population
 Not focusing on neonatal
population.
 Subjective opinions.
 No statistical analysis.
 28.3% of respondents reported
that a pharmacist was prescribing
PN.
 The responsibility for communi-
cating the PN prescription when
a patient makes a care transition
falls primarily to the pharmacist
(35%).
 Several responses reveal that clar-
iﬁcations are not required because
a member of the nutrition support
team, most often a pharmacist,
writes the orders.
 A number of responses indicate
that because a pharmacist or
nutrition team writes the PN
orders, no errors are expected in
the PN process.
14 Mirtallo et al.
(2009)
USA Descriptive review – Adults  Not focusing on neonatal
population.
 Subjective opinion.
 Not mentioning the beneﬁts of
pharmacist writing PN orders.
 The pharmacist role in writing PN
is not clear.
 No statistical analysis.
 The unit-based pharmacist is
responsible for initiation and daily
management of PN along with the
primary service physicians.
 The specialty practice pharmacist
is responsible for oversight of the
PN system throughout the entire
health system.
(continued on next page)
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Table 1 (continued)
Sr. No. Author, year Country Design Number of studies/
respondents/patients
Patients Population
studied
Limitations Main outcomes
15 Faber (1991) USA Descriptive review – Adults  Not focusing on neonatal
population.
 Subjective opinion.
 No statistical analysis.
 The pharmacist serves as a nutri-
tional support therapy consultant
to physicians who wish to have
their patients evaluated, treated,
and monitored by the TPN
service.
 Six staff pharmacists have com-
pleted the training program and
are allowed to write TPN orders
and conduct TPN rounds.
 The program has expanded the
clinical roles of the staff pharma-
cists and has been well received
by the medical staff.
 The quality assurance monitoring
indicates that the service is
excellent.
 A staff development program was
successful in training staff phar-
macists to participate in TPN
therapy.
16 Strausburg
(1995)
USA Summary of
presentation given at
the A.S.P.E.N. 19th
clinical congress and
was previously
published in the
program book
– Adults  Not focusing on neonatal
population.
 Subjective review.
 No statistical analysis.
Nutrition support responsibilities for
clinical pharmacists not solely
dedicated to the team:
 Attend NST rounds on patients in
designated patient care area;
maintain complete list of all
patients in designated patient care
area on PN and EN.
 Assist NST members and others
in designing patient speciﬁc NS
regimens.
17 Dice et al.
(1981)
USA Prospective study 14 patients in each of the 2
study groups
Neonates at neonatal
intensive care unit
 Small sample size.
 Study was carried on peripheral-
vein PN only.
 Focusing on pharmacist moni-
tored PN and not on pharmacist
ordering PN.
Pharmacist monitoring of an
individualized program of TPN in
neonates provided:
 Greater mean daily weight gain,
 Allowed a greater amount of
nutrients to be provided,
 And was cost effective compared
with the use of a standardized
solution without pharmacist
monitoring.
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18 Pedersen et al.
(2011)
USA ASHP national
survey (online
questionnaire).
From the SDI
database of 6975
hospitals, a sampling
frame of 4898
general and
children’s medical–
surgical hospitals in
the United States
was constructed, to
select the sample of
1968 hospitals
A stratiﬁed random sample
of pharmacy directors at
1968 general and children’s
medical–surgical hospitals in
the United States was
surveyed by Internet and
mail
Adults and children  Not focusing on neonatal
population.
 Subjective opinions.
 Focusing on the pharmacist con-
sultation without clear mentioning
on pharmacist writing PN.
 Not clear the impact of pharmacist
involvement.
 2010 survey results: 52.4% of
pharmacy programs provide
nutrition consultation, and when
provided, more than 99.3% have
more than 80% of their consultations
accepted by the prescriber.
 2007 survey results: 48.4% of phar-
macy programs provide nutrition
consultation, and when provided,
more than 98.4% have more than
80% of their consultations accepted
by the prescriber.
 2004 survey results: 51.1% of phar-
macy programs provide nutrition
consultation, and when provided,
more than 91.6% have more than
80% of their consultations accepted
by the prescriber.
 2001 survey results: 46.7% of phar-
macy programs provide nutrition
consultation, and when provided,
more than 76.9% have more than
80% of their consultations accepted
by the prescriber.
19 Gales and Riley
(1994)
USA Prospective study 28 adult patients Adults  Focusing only on adult cases.
 Focusing on the impact of nutri-
tion support team (NST) without
clear mentioning the impact of phar-
macist in PN.
 Patients followed by the NST were
more likely to receive adequate nutri-
tion and experience fewer metabolic
abnormalities than when TPN ther-
apy was guided solely by a physician.
 Evidence demonstrates that physi-
cians have minimal training and expe-
rience in this area of nutrition
support.
PN: parenteral nutrition; ICU’s: intensive care units; TPN: total parenteral nutrition; NST: nutrition support team; NICU: neonatal intensive care unit; ASPEN: American society of parenteral and
enteral nutrition; EN: enteral nutrition; NS: nutrition support; ASHP: American society of health system pharmacists.
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438 M.H. Ragab et al.4. Conﬁrming or modifying the daily amounts of calories
provided (Yang et al., 2013).
5. Adjusting electrolytes additives in PN (Seres et al.,
2006).
6. The oversight of the order-writing process (Seres et al.,
2006).
7. Monitoring neonatal PN (Dice et al., 1981; Mutchie
et al., 1979).
8. Attend NST rounds (Strausburg, 1995).
9. Assist NST members and others in designing patient
speciﬁc NS regimens (Strausburg, 1995).
These diverse activities carried out by pharmacists in the
PN practice, if combined, will deﬁnitely enable the pharmacist
of writing PN orders; either for adults or neonates.
4.3. Beneﬁts of pharmacist involvement in PN
There were 5 articles focusing on the beneﬁts of the pharmacist
involvement in PN which are:
1. More appropriate parenteral nutrition therapy (McDer-
mott et al., 1994).
2. Earlier transitioning from parenteral to enteral nutrition
(McDermott et al., 1994).
3. Recognition of staff pharmacists as resources by the
physicians (McDermott et al., 1994).
4. Increased job satisfaction for pharmacists (McDermott
et al., 1994).
5. Reduce the pharmacy’s costs and patient charges for
TPN (Dice et al., 1981; Mutchie et al., 1979).
6. Improved the patients’ clinical responses to TPN
(Mutchie et al., 1979).
7. Reduction in communication errors (Mulholland, 2013).
8. More integration into the multidisciplinary team (Mul-
holland, 2013).
9. Fewer clariﬁcations are required (Boullata et al., 2013).
10. Less medications errors (Boullata et al., 2013).
11. Greater mean daily weight gain for neonates (Dice et al.,
1981).
12. Greater amount of nutrients to be provided to neonates
(Dice et al., 1981).
4.4. Pharmacist writing PN orders
There were 6 articles focusing on the pharmacist writing PN
orders but in all of them the patients were of mixed population
and/or it was difﬁcult to extract the data for neonates.
1. In the web based survey by Seres et al. (2006), pharmacists
were heavily involved in PN writing process (Seres et al.,
2006).
2. In the review by Greenlaw (1979), the pharmacist is respon-
sible solely of writing PN orders (Greenlaw, 1979).
3. This is from the ASPEN standards of practice for nutrition
support pharmacists stating that nutrition support pharma-
cist may write orders for feeding formulations (Rollins
et al., 2008).
4. In the survey by Boullata et al. (2013), 28.3% of respon-
dents reported that a pharmacist was prescribing PN
(Boullata et al., 2013).5. In the clinical observation review by Mirtallo et al. (2009),
the unit-based pharmacist was responsible for initiation of
PN (Mirtallo et al., 2009).
6. In the descriptive review by Faber (1991), six pharmacists
completed the training program and were allowed to write
PN orders and conduct PN rounds (Faber, 1991).
We noticed that all the 6 articles were either reviews or sur-
veys or poster presentation, and no single clinical trial was
available to judge the practice of pharmacist writing PN
orders; which again raise the need for good quality clinical
research on this area.
4.5. Pharmacist writing neonatal PN orders
Finally we reach to the articles covering the exact scope of this
literature review, and there were only 2 surveys in this group.
1. In the ﬁrst survey by Mansoor et al., 2004, only three of the
surveyed neonatal units reported that the person responsi-
ble for ordering PN was a pharmacist (Ahmed et al., 2004).
2. In the second survey byMulholland (2013), he reported that
the main medications being prescribed by the respondent
pharmacists (n= 45), were parenteral nutrition (75%)
(Mulholland, 2013).
But the limitations for both articles are the lack of objectiv-
ity and small size of the surveys.
Worth mentioning that in the study by Batani et al. (2007),
which was carried out at USM, Malaysia (Batani et al., 2007),
the rate of electrolyte and metabolic complications was 56.5%
which is higher compared with that in developed countries,
also in this study the pharmacist role was only compounding
of the PN admixtures (Batani et al., 2007).
While in the study of Gales and Riley (1994), they demon-
strated that adding a pharmacist to the nutrition support team
with direct interventions in the nutritional care plan, will
reduce the metabolic and electrolyte complications associated
with parenteral nutrition therapy (Gales and Riley, 1994).
This could make us assume that in the study of Batani et al.
(2007). If the pharmacists had better role in the PN process this
could have reduced the metabolic and electrolyte complica-
tions encountered.
5. Conclusion
Overall, the review presents the up-to-date status of the most
recent analysis being undertaken on the topic of pharmacist
involvement in the parenteral nutrition order writing practices
and more speciﬁc in the neonatal population over the period
from 1979 to 2013.
The overall impression is that the practice of pharmacist
writing neonatal parenteral nutrition orders already exists,
but still limited if compared with the practice pharmacist writ-
ing adult parenteral nutrition orders which is much more
established in many countries.
It is very difﬁcult to assess the usefulness of the practice of
pharmacist writing neonatal parenteral nutrition orders in the
view of lack of good quality clinical trials evaluating this prac-
tice in the real life, there was no single clinical study evaluating
this practice, as we were able to retrieve only two surveys.
Neonatal parenteral nutrition 439Nevertheless, despite the wide variation in literature types,
characteristics and quality, there are consistent patterns across
all the reviewed literature that competencies of the pharmacist
in this ﬁeld are well represented, which make it very important
to carry out good quality clinical studies to assess the clinical
beneﬁts of the pharmacist involvement in writing neonatal par-
enteral nutrition orders.
Finally, based on all these ﬁndings, we are currently con-
ducting a prospective clinical study with historical cohort con-
trol – at Prince Salman Northwestern Armed Forces Hospital,
Tabuk – to evaluate the impact of clinical pharmacist as a neo-
natal PN prescriber, this impact will be judged through the
study outcomes as reducing the metabolic and electrolytes
complications and increasing the mean daily weight gain dur-
ing PN therapy and reducing the average number of days of
PN till enteral feeding is achieved.
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